![]() |
市场调查报告书
商品编码
1625425
胃肠产品市场、规模、占有率、趋势、行业分析报告(按设备、疾病、最终用户和地区)- 市场预测,2025-2034 年Gastrointestinal Products Market Size, Share, Trends, Industry Analysis Report: By Devices, Disease, End User, and Region - Market Forecast, 2025-2034 |
根据Polaris Market Research的最新研究,到2034年胃肠产品市场规模预计将达到258.5亿美元。该报告提供了对当前市场动态的详细见解,并对未来市场成长进行了分析。
胃肠道疾病的盛行率不断上升,例如胃食道逆流(GERD)、发炎性肠道疾病(IBD)和肠躁症(IBS)等,是推动胃肠道产品市场成长的常见疾病。随着这些疾病变得越来越普遍,对有效治疗的需求也日益增长,製药公司也在扩大其产品阵容。此外,药物配方和药物传递系统的创新为患者带来了更有效、更易于使用的治疗方法,并提高了患者的依从性。人们对消化系统健康的认识和早期介入的重要性的提高进一步强化了这一趋势,鼓励患者及时寻求洞察力驱动的治疗方案。
医疗保健领域的技术整合,特别是透过远距医疗和数位健康技术(如远距医疗平台、电子健康记录 (EHR) 和行动健康应用程式)正在改变胃肠道护理的格局。这些技术创新将改善患者获得医疗服务的机会,实现远距咨询和有效管理胃肠道疾病。患者现在可以获得医疗专业人员的及时诊断和持续支持,而无需亲自就诊,这对于居住在偏远地区的人们尤其有益。此外,行动健康应用等数位工具可以帮助患者监测症状、追踪饮食习惯并获得个人化的治疗计划,以促进更好的健康结果。因此,这种转变提高了患者的便利性,并促进了积极主动的胃肠道健康管理方法,最终有助于提高满意度和依从性。
按疾病划分,到 2024 年,胃食道逆流症 (GERD) 因其广泛的流行程度和社会认知度的提高,将成为全球胃肠道产品市场的主要细分领域。
由于人们对门诊手术的偏好日益增加,门诊手术中心(ASC)部门在胃肠产品市场中正经历快速成长。
2024年,北美引领胃肠道产品市场,这主要是由于胃食道逆流症 (GERD) 和发炎性肠道疾病 (IBD) 等胃肠道疾病的流行。
由于医疗保健支出不断增加、人们对胃肠道健康的认识不断提高以及越来越多的人面临与生活方式相关的问题,预计亚太地区将在预测期内以最快的速度增长。
全球主要市场参与者包括Abbott Laboratories; Johnson & Johnson; Pfizer Inc.; Bayer AG; Astellas Pharma Inc.; Takeda Pharmaceutical Company; Novartis International AG; GSK (GlaxoSmithKline); Mylan N.V.; Santen Pharmaceutical Co., Ltd.; Dr. Reddy's Laboratories Ltd.。
The gastrointestinal products market size is expected to reach USD 25.85 billion by 2034, according to a new study by Polaris Market Research. The report "Gastrointestinal Products Market Size, Share, Trends, Industry Analysis Report: By Devices, Disease, End User (Hospitals, Ambulatory Centers and Independent Diagnostic Centers, Clinics, Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa); Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising prevalence of gastrointestinal disorders, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and irritable bowel syndrome (IBS), are among the prevailing diseases driving the gastrointestinal products market growth. Since these conditions have become more common, there is a greater demand for effective treatments, prompting pharmaceutical companies to enhance their product offerings. Additionally, innovations in drug formulations and delivery systems have led to the development of therapies that are more effective and easier for patients to use, thereby improving compliance. This growing awareness of digestive health and the importance of early intervention further reinforces this trend, encouraging patients to seek timely treatment options led to insights.
Technological integration in healthcare, such as telemedicine platforms, electronic health records (EHRs), and mobile health applications, particularly through telemedicine and digital health technologies, is transforming the landscape of gastrointestinal care. These innovations enhance patient access to medical services, enabling remote consultations and effective management of gastrointestinal disorders. Patients are now able to receive timely diagnoses and ongoing support from healthcare professionals without the need for in-person visits, which is especially beneficial for those living in remote areas. Additionally, digital tools such as mobile health apps allow patients to monitor their symptoms, track dietary habits, and receive personalized treatment plans, promoting better health outcomes. Therefore, this shift has improved patient convenience, promoting a proactive approach to gastrointestinal health management and ultimately contributing to increased satisfaction and compliance.
In terms of disease, in 2024, gastroesophageal reflux disease (GERD) has emerged as the leading segment in the global gastrointestinal products market due to its widespread prevalence and growing public awareness.
The ambulatory surgical centers (ASCs) segment is witnessing rapid growth in the gastrointestinal products market, driven by an increasing preference for outpatient procedures.
In 2024, North America led the gastrointestinal products market, largely due to the prevalence of gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and inflammatory bowel disease (IBD).
Asia Pacific is projected to experience the fastest growth during the forecast period, driven by increasing healthcare spending, heightened awareness of gastrointestinal health, and a rising population grappling with lifestyle-related issues.
A few global key market players include Abbott Laboratories; Johnson & Johnson; Pfizer Inc.; Bayer AG; Astellas Pharma Inc.; Takeda Pharmaceutical Company; Novartis International AG; GSK (GlaxoSmithKline); Mylan N.V.; Santen Pharmaceutical Co., Ltd.; Dr. Reddy's Laboratories Ltd.
Polaris Market Research has segmented the gastrointestinal products market report on the basis of devices, disease, end user, and region:
Table 1 Global Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 2 Global Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 3 Global Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 4 North America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 5 North America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 6 North America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 7 US: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 8 US: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 9 US: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 10 Canada: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 11 Canada: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 12 Canada: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 13 Europe: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 14 Europe: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 15 Europe: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 16 UK: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 17 UK: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 18 UK: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 19 France: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 20 France: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 21 France: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 22 Germany: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 23 Germany: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 24 Germany: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 25 Italy: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 26 Italy: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 27 Italy: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 28 Spain: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 29 Spain: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 30 Spain: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 31 Netherlands: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 32 Netherlands: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 33 Netherlands: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 34 Russia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 35 Russia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 36 Russia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 37 Rest of Europe: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 38 Rest of Europe: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 39 Rest of Europe: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 40 Asia Pacific: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 41 Asia Pacific: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 42 Asia Pacific: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 43 China: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 44 China: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 45 China: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 46 India: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 47 India: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 48 India: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 49 Malaysia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 50 Malaysia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 51 Malaysia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 52 Japan: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 53 Japan: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 54 Japan: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 55 Indonesia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 56 Indonesia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 57 Indonesia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 58 South Korea: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 59 South Korea: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 60 South Korea: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 61 Australia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 62 Australia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 63 Australia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 64 Rest of Asia Pacific: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 65 Rest of Asia Pacific: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 66 Rest of Asia Pacific: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 67 Middle East & Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 68 Middle East & Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 69 Middle East & Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 70 Saudi Arabia: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 71 Saudi Arabia: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 72 Saudi Arabia: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 73 UAE: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 74 UAE: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 75 UAE: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 76 Israel: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 77 Israel: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 78 Israel: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 79 South Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 80 South Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 81 South Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 82 Rest of Middle East & Africa: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 83 Rest of Middle East & Africa: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 84 Rest of Middle East & Africa: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 85 Latin America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 86 Latin America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 87 Latin America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 88 Mexico: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 89 Mexico: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 90 Mexico: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 91 Brazil: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 92 Brazil: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 93 Brazil: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 94 Argentina: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 95 Argentina: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 96 Argentina: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
Table 97 Rest of Latin America: Gastrointestinal Products Market, by Devices, 2020-2034(USD Billion)
Table 98 Rest of Latin America: Gastrointestinal Products Market, by Disease, 2020-2034(USD Billion)
Table 99 Rest of Latin America: Gastrointestinal Products Market, by End User, 2020-2034(USD Billion)
List of Figures:
Figure 1. Global Gastrointestinal Products Market, 2020-2034(USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Devices
Figure 7. Global Gastrointestinal Products Market, by Devices, 2023 & 2032 (USD Billion)
Figure 8. Market by Disease
Figure 9. Global Gastrointestinal Products Market, by Disease, 2023 & 2032 (USD Billion)
Figure 10. Market by End User
Figure 11. Global Gastrointestinal Products Market, by End User, 2023 & 2032 (USD Billion)